Evidence map›Paper›PMID 38842764›Full record

Trial reportClinical drug investigation2024

A Randomized Control Trial of Dexketoprofen/Vitamin B (Thiamine, Pyridoxine and Cyanocobalamin) Fixed-Dose Combination in Post-Traumatic Grade I-II Cervical Sprains.

Pamela Delgado-García, Juan Bautista Alcocer-Herrera, Adelfia Urenda-Quezada, María Dolores Alonso-Martinez, María Arcelia Bautista-Mendoza, Yulia Romero-Antonio, Julio C Mora-Villalobos, José G Sander-Padilla, Kevin F Rios-Brito, Ileana C Rodríguez-Vazquez and 1 more

Registry-linked trialAbstract readRandomized Controlled TrialMulticenter StudyClinical Trial, Phase III
In one paragraph

Trial report in Clinical drug investigation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05001555 (Efficacy and Safety of the Combination Dexketoprofen / Vitamin B Vs Dexketoprofen in the Treatment of Pain in Patients with Post-traumatic Cervical Sprain Grade I-II of the Quebec Scale.), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05001555 phase3completednot on this map

Efficacy and Safety of the Combination Dexketoprofen / Vitamin B Vs Dexketoprofen in the Treatment of Pain in Patients with Post-traumatic Cervical Sprain Grade I-II of the Quebec Scale.

TypeinterventionalSponsorLaboratorios Silanes S.A. de C.V.Ran2021 to 2023Enrolled174ConditionsAcute Low Back PainArmsDexketoprofen/Vitamin B, Dexketoprofen
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Pamela Delgado-GarcíaIMACEN S.A. de C.V., Chihuahua, Mexico.ORCID http://orcid.org/0009-0002-7706-5665
Juan Bautista Alcocer-HerreraINBIOMEDyC Queretaro, Santiago de Querétaro, Mexico.
Adelfia Urenda-QuezadaTraumatology Area of Mediadvance Clinical S.A.P.I. de C.V., Chihuahua, Mexico.ORCID http://orcid.org/0000-0002-6305-9013
María Dolores Alonso-MartinezCentro de Investigacion Clinica de Mexico, S. de R.L. de C.V. Morelia, Michoacan, Mexico.ORCID http://orcid.org/0009-0005-3436-3955
María Arcelia Bautista-MendozaDepartment of Traumatology and Orthopedics, Sanatorio Alcocer Pozo S.A. de C.V., Santiago de Querétaro, Mexico.ORCID http://orcid.org/0009-0006-3008-8527
Yulia Romero-AntonioResearch and Development Department of Laboratorios Silanes, S.A. de C.V., Av. De las Palmas No. 340, 3rd floor, Lomas de Chapultepec, Miguel Hidalgo, 11000, Mexico City, Mexico.ORCID http://orcid.org/0000-0003-2613-1714
Julio C Mora-VillalobosResearch and Development Department of Laboratorios Silanes, S.A. de C.V., Av. De las Palmas No. 340, 3rd floor, Lomas de Chapultepec, Miguel Hidalgo, 11000, Mexico City, Mexico.ORCID http://orcid.org/0009-0005-4164-4122
José G Sander-PadillaResearch and Development Department of Laboratorios Silanes, S.A. de C.V., Av. De las Palmas No. 340, 3rd floor, Lomas de Chapultepec, Miguel Hidalgo, 11000, Mexico City, Mexico.ORCID http://orcid.org/0000-0002-4832-4624
Kevin F Rios-BritoResearch and Development Department of Laboratorios Silanes, S.A. de C.V., Av. De las Palmas No. 340, 3rd floor, Lomas de Chapultepec, Miguel Hidalgo, 11000, Mexico City, Mexico.ORCID http://orcid.org/0009-0003-7012-3831
Ileana C Rodríguez-VazquezResearch and Development Department of Laboratorios Silanes, S.A. de C.V., Av. De las Palmas No. 340, 3rd floor, Lomas de Chapultepec, Miguel Hidalgo, 11000, Mexico City, Mexico.ORCID http://orcid.org/0000-0001-8578-3742
Jorge González-CanudasResearch and Development Department of Laboratorios Silanes, S.A. de C.V., Av. De las Palmas No. 340, 3rd floor, Lomas de Chapultepec, Miguel Hidalgo, 11000, Mexico City, Mexico. jogonzalez@silanes.com.mx.ORCID http://orcid.org/0000-0001-7412-6499

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMusculoskeletal disorders are an important cause of work absence. Clinical practice guidelines recommend nonsteroidal anti-inflammatory drugs (NSAIDs) for grade I-II cervical sprains. The combination of thiamine + pyridoxine + cyanocobalamin vitamins has been used, alone and in combination with NSAIDs, for pain and inflammation in musculoskeletal disorders.

objectiveThe objective of this study was to demonstrate the analgesic synergy of dexketoprofen, and the combination of vitamins thiamine + pyridoxine + cyanocobalamin in a fixed-dose combination (FDC) for the treatment of acute pain caused by grade I-II cervical sprains.

methodsWe conducted a multicentre, prospective, randomized, double-blind, phase IIIb clinical study comparing two treatment groups: (1) dexketoprofen 25 mg/vitamin B (thiamine 100 mg, pyridoxine 50 mg and cyanocobalamin 0.50 mg) in an FDC (two or more active ingredients combined in a single dosage form) versus (2) dexketoprofen 25 mg monotherapy (single drug to treat a particular disease), one capsule or tablet orally, every 8 h for 7 days. Final mean, average change, and percentage change in pain perception (measured using a visual analogue scale [VAS]) were compared with baseline between groups. A p value < 0.05 was considered statistically significant. Analyses were conducted using SPSS software, v.29.0.

resultsA statistically significant reduction in pain intensity was observed from the third day of treatment with the FDC compared with monotherapy (- 3.1 ± - 1.5 and - 2.6 ± - 1.1 cm, respectively) measured using the VAS (p = 0.011). Regarding the degree of disability, using the Northwick Park Neck Pain Questionnaire (NPQ), statistical difference was observed for the final measurement (7.5%, interquartile range [IQR] 2.5, 10.5; vs. 7.9%, IQR 5.0, 13.8; p = 0.028). A lower proportion of adverse events was reported when using the FDC.

conclusionsThe FDC of dexketoprofen/thiamine + pyridoxine + cyanocobalamin vitamins demonstrated superior efficacy and a better safety profile compared with dexketoprofen monotherapy for pain treatment in patients with grade I-II cervical sprains. CLINICAL TRIALS REGISTRATION: NCT05001555, registered 29 July 2021 ( https://clinicaltrials.gov/study/NCT05001555 ).

Indexed as

Anti-Inflammatory Agents, Non-SteroidalDrug CombinationsKetoprofenPyridoxineThiamineTromethamineVitamin B 12AdultDouble-Blind MethodFemaleHumansMaleMiddle AgedPain MeasurementProspective StudiesVitamin B ComplexAnti-Inflammatory Agents, Non-Steroidaldexketoprofen trometamolDrug CombinationsKetoprofenPyridoxineThiamineTromethamineVitamin B 12Vitamin B Complex

Identifiers

PMID38842764
PMCPMC11196333

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.